General Methods for Chemistry.
Copy of 1H-and 13C-NMR Spectra for Compound X22..................................... . 46 X22...................................................... thio)hexyl)isoindoline-1, 3-dione (7d) . Yield 90%; 1 H NMR (400 MHz, CDCl3) δ 8.11 (d, J = 8.6 Hz, 2H), 7.84 (dd, J = 5.5, 3 .0 Hz, 2H), 7.72 (dd, J = 5.4, 3.1 Hz, 2H), 7.30 (d, J = 8.7 Hz, 2H) , 3.69 (t, J = 7.2 Hz, 2H), 3.01 (t, J = 7.3 Hz, 2H), 1.73 (d, J = 7.3 Hz, 4H), 1.53 (m, 2H), 1.40 (m, 2H); 13 C NMR (101 MHz, CDCl3) δ 168.5, 148.0, 145.0, 134.0, 132.2, 126.2, 124.0, 123.3, 37.9, 31.9, 29.1, 28.5, 28.4, thio)heptyl)isoindoline-1, 3-dione (7e) . Yield 95%; 1 H NMR (400 MHz, CDCl3) δ 8.14 -8.08 (m, 2H), 7.83 (dd, J = 5.5, 3 .0 Hz, 2H), 7.71 (dd, J = 5.5, 3.1 Hz, 2H), 7.32 -7.27 (m, 2H) , 3.67 (t, J = 7.3 Hz, 2H), 2.99 (t, J = 7.3 Hz, 2H), 1.73 -1.65 (m, 4H), 1.46 (m, 2H), 1.37 (m, 4H); 13 C NMR (101 MHz, CDCl3) δ 168. 6, 148.2, 145.0, 134.0, 132.2, 126.1, 124.1, 123.3, 38.0, 32.0, 28.8, 28.7, 28.6, 28.5, phenyl)thio)pentyl)isoindoline-1, 3-dione (7f) . Intermediate 7f was prepared using 4-fluoro-1-nitro-2-(trifluoromethyl)benzene (6d) instead of 6a with the method D in 95% yield; 1 H NMR (400 MHz, CDCl3) 5, 146.6, 134.1, 132.2, 129.2, 126.1, 125.4, 125.3, 125.3, 124.8, 123.4, 120.6, 37.6, 32.0, 28.1, 27.9, thio)pentyl)isoindoline-1, 3-dione (7g) .
Copy of HRMS Spectra for Compound
Intermediate 7g was prepared using 4-fluoro-2-methyl-1-nitrobenzene (6b) instead of 6a with the method D in 94% yield; 1 H NMR (400 MHz, 1H), 7.83 (dd, J = 5.4, 3 .1 Hz, 2H), 7.71 (dq, J = 6.6, 3.9 Hz, 2H), 7.12 (d, J = 7.5 Hz, 2H) , 3.69 (t, J = 7.1 Hz, 2H), 2.98 (t, J = 7.3 Hz, 2H), 2.59 (s, 3H), 1.78 -1.69 (m, 4H), 1.51 (m, 2H); 13 C NMR (101 MHz, CDCl3) δ 168. 5, 147.1, 145.7, 134.9, 134.1, 132.2, 129.9, 125.6, 124.2, 123.3, 37.7, 31.8, 28.3, 28.2, 26.1, thio)pentyl)isoindoline-1, 3-dione (7h) .
Intermediate 7h was prepared using 4-fluoro-2-methoxy-1-nitrobenzene (6c) instead of 6a with the method D in 79% yield; 1 H NMR (400 MHz, CDCl3) 5, 153.6, 147.4, 136.3, 134.1, 132.1, 126.7, 123.3, 117.5, 111.1, 56.7, 37.7, 32 .0, 28.2, 28.1, 26.1.
General method E for preparation of 12a~12e
Potassium carbonate (2.0 eq) was added slowly to solution of 5a~5e (9 mmol, 1.0 eq) in 20 mL DMF and the mixture was stirred for 10 min.
1-(bromomethyl)-4-nitrobenzene (1.2 eq) was added to the mixture solution above.
Continuous stirring at room temperature for 4.5 h until no more start materials could be detected by TLC, the reaction was quenched with water (30 mL) and extracted with ethyl acetate (30 mL×3). Organic layer was washed with saturated NaHCO3 and NaCl in turn, then dried with anhydrous Na2SO4. Through filtered via suction, the crude product was concentrated in vacuo. The pure product was recrystallized within mixture solution of ethyl acetate and petroleum ether to give the intermediates 12a~12e as light-yellow solid. 132.1, 129.8, 123.9, 123.4, 37.0, 35.5, 28.5, 5, 147.0, 146.5, 134.1, 132.1, 129.7, 123.9, 123.3, 37.4, 35.9, 31.2, 27.8, 5, 147.0, 146.6, 134.0, 132.2, 129.7, 123.8, 123.3, 37.7, 35.8, 31.3, 28.6, 28.2, 6, 147.0, 146.6, 134.0, 132.2, 129.7, 123.9, 123.3, 37.9, 35.8, 31.5, 29.0, 28.5, 28.4, 6, 150.0, 146.7, 134.0, 132.3, 129.7, 123.9, 123.3, 38.0, 35.9, 31.6, 29.0, 28.8, 28.7, 28.6, 26.7. 1.6. General method F for preparation of 8a~8e and 13a~13e
A solution of intermediates 7a~7b or 12a~12e (2.5 mmol) in dichloromethane (20 mL) were cooled to 0°C in ice-water bath. A solution of 85% m-CPBA (4.5 eq) of DCM (10 mL) was added dropwise over 10 min keeping the temperature at 0°C.
When the addition was finished, the mixture was warm to room temperature and stirred for 2 h. After completion of reaction, the reaction was quenched with saturated Na2SO3 solution and stirred for a while. The organic phase was washed with brine, dried with anhydrous Na2SO4. After filtered, the product was concentrated with rotary evaporator to give the intermediates 8a~8e or 13a~13e as white solid.
1. 3, 144.5, 134.5, 131.9, 129.9, 127.4, 124.7, 123.6, 54.0, 36.3, 5, 147.4, 134.2, 134.1, 132.0, 126.4, 124.1, 123.4, 37.3, 31.4, 27.7, 5, 151.0, 144.8, 134.2, 132.1, 129.7, 124.6, 123.4, 56.0, 37.4, 28.1, 25.5, 22 .2.
1. 5, 151.0, 144.9, 134.1, 132.2, 129.8, 124.7, 123.4, 56.2, 37.7, 28.2, 27.8, 26.2, 6, 151.0, 144.9, 134.1, 132.2, 129.7, 124.6, 123.3, 56.2, 37.8, 28.5, 28.4, 28.2, 26.4, 164.6, 134.6, 134.6, 131.9, 131.8, 124.3, 123.6, 58.8, 49.8, 36.3, 148.5, 134.8, 134.3, 132.0, 131.9, 124.2, 123.5, 58.8, 51.7, 36.8, 27.4, 19. 3.
1. 6, 148.4, 135.0, 134.1, 132.2, 131.8, 124.3, 123.4, 58.6, 52.1, 37.6, 28.2, 27.9, 26 .2, 21.9.
1.6.10. 2- 6, 148.5, 135.0, 134.1, 132.2, 131.8, 124.3, 123.3, 58.7, 52.2, 37.8, 28.5, 28.4, 28.3, 26 .4, 21.8.
General method E1 and E2 for preparation of 9a~10e and 14a~15e
Method E1: To a stirred solution of the yellow solid 7a, 7c, 7f~7h, 8a~8e or 13a~13e (1.0 eq) in AcOH (reaction concentration: 0.1 mmol/mL), Fe powder (11 eq) was added in portion, and the mixture was refluxed at 65°C. After the completion of the reaction, the reaction mixture was absorbed onto celite, washed with dichloromethane, concentrated under reduced pressure. The crude product was purified by silica gel column chromatography to afford intermediates 9a~10e or 15a~15e as yellow oil.
Method E2: To a stirred solution of the yellow solid 12a~13e (1.0 eq) and ammonium chloride (9.0 eq) in MeOH (reaction concentration: 0.1 mmol/mL), Zn powder (7.0 eq) was added in several portion, and the mixture was stirred at RT for 1.5h. After the completion of the reaction, the reaction mixture was absorbed onto celite, concentrated under reduced pressure. The crude product was purified by silica gel column chromatography to afford intermediates 14a~14e as yellow oil. 6, 136.9, 134.3, 131.6, 129.6, 129.6, 129.5, 129.5, 126.0, 122.9, 119.4, 117.7, 110.8, 37.2, 35.0, 28.2, 27.4, 131.6, 130.9, 123.0, 121.8, 119.3, 114.4, 37.3, 35.4, 28.3, 27.5, 25.1, 5, 151.5, 134.1, 132.2, 130.2, 127.1, 123.3, 114.2, 56.5, 37.7, 28.3, 25.7, 6, 123.3, 114.3, 56.8, 38.0, 28.7, 28.5, 28.3, 26.6, 134.3, 131.7, 129.4, 124.7, 123.0, 113.7, 36.7, 34.6, 27.6, 6, 146.0, 134.1, 132.0, 129.8, 128.6, 123.3, 116.4, 38.2, 35.9, 31.2, 27.8, 6, 145.0, 134.0, 132.2, 129.9, 128.6, 123.3, 115.4, 38.0, 35.9, 31.0, 28.9, 28.3, 6, 134.0, 132.3, 129.9, 129.6, 124.7, 123.3, 116.2, 38.1, 35.9, 31.2, 29.2, 28.6, 28.5, 147.4, 134.4, 131.6, 129.4, 125.0, 123.0, 113.7, 37.3, 34.9, 30.4, 28.7, 28.6, 28.1, 27.9, 2, 147.4, 134.3, 132.1, 131.6, 123.5, 117.1, 115.4, 59.3, 48.4, 36.5, 4, 147.4, 134.2, 132.1, 131.7, 123.4, 117.2, 115.5, 59.3, 50.1, 37.1, 27.5, 6, 147.4, 134.0, 132.3, 131.6, 123.3, 117.6, 115.5, 59.3, 50.7, 38.0, 28.6, 28.6, 28.4, 26.6, 21 .9.
General method F for preparation of 17a~20e
The intermediates 9a~10e or 14a~15e
(1.0 eq), 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide (16, 1.0 eq), Pd(OAc)2 (0.1 eq), BINAP (0.06 eq), Cs2CO3 (2.0 eq) were dissolved in 1,4-dioxane and degassed with argon. The resulted mixture was heated to 105°C for 7 h. After monitored by TLC to observe completion of reaction, the reaction mixture was filtered through Celite after cooling to 25°C, then the solvents were removed in vacuo. The crude product was purified by silica gel column chromatography to afford intermediates 17a~20e as light-yellow solid.
1.8.1.
7-Cyclopentyl-2-((4-((3-(1,3-dioxoisoindolin-2-yl)propyl)thio)phenyl)amino)-N,N-dim
ethyl-7H-pyrrolo [2,3-d] 5, 164.0, 155.0, 151.9, 151.6, 136.5, 134.4, 134.0, 132.7, 132.2, 129.4, 128.4, 128.3, 125.5, 123.3, 122.9, 113.3, 100.9, 100.1, 57.9, 39.5, 37.9, 34.9, 30.6, 28.9, 28.3, 26.1, -(1,3-dioxoisoindolin-2-yl) pentyl)thio)-2-methylphenyl)amino) -N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (17d 5, 164.2, 155.8, 152.1, 151.8, 137.2, 134.0, 133.0, 132.2, 132.0, 129.2, 128.7, 127.9, 123.3, 120.6, 112.5, 101.0, 57.9, 38.0, 35.2, 30.5, 29.8, 29.1, 28.3, 26.1, 24.9, 5, 164.2, 155.3, 152.1, 151.7, 147.8, 134.0, 132.2, 131.9, 129.1, 127.0, 124.0, 123.3, 117.9, 113.4, 112.3, 101.1, 58.1, 56.0, 38.0, 35.7, 30.2, 29.8, 29.1, 28.3, 26.1, propyl)sulfonyl)phenyl)amino)-N,N -dimethyl-7H-pyrrolo [2,3-d] 9, 162.8, 154.6, 152.0, 150.8, 145.9, 134.2, 132.6, 131.8, 129.2, 128.8, 122.9, 117.3, 112.5, 100.5, 62.8, 57.0, 52.8, 36.0, 29.7, 24.2, butyl)sulfonyl)phenyl)amino)-N, N-d imethyl-7H-pyrrolo[2,3-d] 3, 163.9, 154.4, 151.7, 151.5, 145.3, 134.1, 133.1, 132.1, 130.3, 129.5, 123.4, 117.7, 113.4, 100.9, 58.2, 56.0, 37.0, 30.3, 29.8, 27.2, 24.8, 6-carboxamide (18c 5, 163.9, 154.4, 151.7, 151.6, 145.3, 134.1, 133.1, 132.1, 130.4, 129.5, 123.3, 117.7, 113.4, 100.9, 58.2, 56.5, 39.5, 37.6, 30.3, 28.3, 25.8, 24.8, -((6-(1,3-dioxoisoindolin-2-yl) 5, 163.9, 154.4, 151.7, 151.6, 145.3, 134.0, 133.1, 132.2, 130.5, 129.5, 123.3, 117.7, 113.4, 100.9, 58.2, 56.6, 39.5, 37.8, 30.3, 28.4, 28.0, 26.4, 24.8, 6, 163.9, 154.5, 151.7, 151.7, 145.2, 134.0, 133.0, 132.2, 130.6, 129.5, 123.3, 117.7, 113.5, 100.9, 58.2, 56.7, 39.6, 37.9, 30.3, 28.7, 28.5, 28.3, 26.6, 24.8, propyl)thio)methyl)phenyl)amino)-N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (19a 4, 164.2, 155.4, 152.2, 151.6, 139.1, 134.0, 132.2, 132.1, 131.3, 129.4, 123.3, 118.7, 112.4, 101.1, 60.5, 58.1, 37.3, 35.6, 30.3, 28.3, 28.2, -(((4-(1,3-dioxoisoindolin-2-yl) 4, 164.2, 155.5, 152.1, 151.7, 139.2, 133.9, 132.1, 131.8, 131.5, 129.2, 123.2, 118.7, 112.3, 101.0, 57.9, 39.5, 37.5, 35.9, 30.8, 30.2, 27.8, 26.5, pentyl)thio)methyl)phenyl)amino)-N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (19c 5, 164.2, 155.5, 152.2, 151.6, 139.1, 134.0, 132.2, 132.0, 131.8, 129.3, 123.3, 118.8, 112.3, 101.1, 58.0, 37.9, 35.9, 31.1, 30.3, 29.8, 28.9, 28.3, 26.2, hexyl)thio)methyl)phenyl)amino)-N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (19d 6, 164.2, 155.5, 152.2, 151.6, 139.1, 134.0, 132.3, 132.0, 131.9, 129.4, 123.3, 118.7, 112.4, 101.1, 72.9, 58.1, 53.6, 38.1, 35.9, 31.2, 30.3, 29.2, 28.5, 26.6, 24.8. 1.8.15. 7-cyclopentyl-2-((4-(((7-(1,3-dioxoisoindolin-2-yl) heptyl)thio)methyl)phenyl)amino)-N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (19e 6, 164.2, 155.5, 152.2, 151.6, 139.0, 134.0, 132.3, 132.1, 131.9, 129.4, 123.3, 118.8, 112.4, 101.1, 58.1, 38.1, 36.0, 35.3, 31.3, 30.3, 29.3, 28.9, 28.8, 28.7, 26.8, 24.8. 1.8.16. 7-cyclopentyl-2-((4-(((3-(1,3-dioxoisoindolin-2-yl) propyl)sulfonyl)methyl)phenyl)ami no)-N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (20a 2, 164.1, 155.1, 152.0, 151.7, 141.1, 134.2, 132.3, 131.9, 131.0, 123.5, 120.4, 118.8, 112.7, 101.0, 59.3, 58.0, 48.6, 39.6, 36.4, 30.3, 24.8, butyl)sulfonyl)methyl)phenyl)amin o)-N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (20b 152.1, 151.5, 141.1, 134.2, 132.4, 132.1, 131.2, 123.5, 120.7, 118.9, 112.8, 101.1, 59.4, 58.1, 50.3, 39.6, 37.1, 30.3, 27.5, 24.8, 5-(1,3-dioxoisoindolin-2-yl) pentyl)sulfonyl)methyl)phenyl)ami no)-N, N-dimethyl-7H-pyrrolo[2,3-d] pyrimidine- 6-carboxamide (20c 5, 164.1, 155.2, 152.0, 151.7, 141.1, 134.1, 132.3, 132.1, 131.1, 123.4, 120.7, 118.8, 112.8, 101.0, 59.3, 58.0, 50.7, 39.5, 37.5, 30.3, 28.2, 25.8, 24.8, 6-carboxamide (20d 5, 164.1, 155.2, 152.0, 151.7, 141.1, 134.1, 132.3, 132.2, 131.1, 123.3, 120.8, 118.9, 112.8, 101.0, 59.2, 58.1, 50.8, 39.5, 37.7, 30.3, 28.3, 28.1, 26.4, 24.8, 6, 164.1, 157.0, 154.1, 152.2, 141.1, 134.0, 132.6, 132.3, 131.1, 123.3, 121.0, 119.0, 112.8, 101.1, 59.3, 58.1, 51.0, 38.0, 30.4, 29.8, 28.7, 28.5, 28.4, 26.5, 24.8, 21 .9.
1.9. General method G1-G3 for preparation of X1~X23
Method G1: To a stirred solution of 17a~20e (1.0 eq) in MeOH, hydrazine hydrate (80%, 6.0 eq) was added, then stirred 3 h at 60°C. After removing solvent in vacuo, the residue was dissolved in n-butanol (10 mL) and washed with saturated Na2CO3 solution and brine. The organic layer was concentrated under reduced pressure to use directly without purification. After dissolving the resulting light-yellow oil in THF (5 mL), carbon disulphide (20 equiv), DCC (1.4 eq) were added in successively, stirred overnight at RT. The solvent was concentrated in vacuo and crude product was purified by silica gel column chromatography to give target compound X1~X23 (except X5~X7) as light-yellow solid or oil.
Method G2: A solution of compounds X1 or X4 (1.0 eq) in dichloromethane (5 mL) were cooled to -10°C. A solution of 85% m-CPBA (1.5 eq) of DCM (5 mL) was added dropwise over 10 min keeping the temperature below 0°C. When the addition was finished, the mixture was warm to 0°C and stirred for 2 h. After completion of reaction, the reaction was quenched with saturated Na2SO3 solution and stirred for a while. The organic phase was washed with brine, dried with anhydrous Na2SO4. The crude product was concentrated with rotary evaporator and purified through silica gel column chromatography to give the target compounds X5 or X7 as white solid.
Method G3: A solution of compounds X4 (1.0 eq) in dichloromethane (5 mL) were cooled to 0°C. A solution of 85% m-CPBA (4.5 eq) of DCM (5 mL) was added dropwise over 10 min keeping the temperature at 0°C. Then stirred at room temperature for 2 h. The reaction was quenched with saturated Na2SO3 solution and stirred for a while. The organic phase was washed with brine, dried with anhydrous Na2SO4. The crude product was concentrated with rotary evaporator and purified through silica gel column chromatography to give the target compounds X6 as white solid.
1.9.1. 1, 155.3, 152.1, 151.7, 139.4, 132.3, 132.3, 132.2, 127.5, 119.2, 112.6, 101.1, 58.0, 45.0, 35.4, 34.1, 30.3, 29.7, 28.6, 25.7, 24.8 154.9, 151.8, 151.6, 136.8, 134.7, 132.7, 128.8, 128.6, 128.6, 125.5, 122.8, 119.6, 119.3, 113.3, 100.9, 57.9, 45.0, 39.5, 34.9, 30.6, 29.6, 28.5, 25.7, 25. 8, 154.2, 151.7, 151.5, 140.9, 135.4, 133.2, 128.3, 125.3, 122.8, 122.7, 122.6, 121.4, 118.5, 118.2, 113.9, 100.8, 57.9, 57.1, 44.8, 30.6, 29.8, 29.7, 25.8, 24.9, 21.7; HRMS (ESI, m/z) calcd for C27H32F3N6O2S2 + [M + H] + , 593.1975, found 593.1972 .
HPLC purity 98%.
1.9. sulfonyl)-2-(trifluoromethyl)phenyl)ami no)-N, N-dimethyl-7H-pyrrolo[2,3-d] 
